Patents by Inventor Melissa Dormitzer

Melissa Dormitzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents
    Publication number: 20090148459
    Abstract: The present invention relates to methods and compositions designed for the treatment, management or prevention of cancer. The methods of the invention comprise the administration of an effective amount of one or more antagonists of Integrin ?V?3 alone or in combination with the administration of an effective amount of one or more other agents useful for cancer therapy. The invention also provides pharmaceutical compositions comprising one or more antagonists of Integrin ?V?3 and/or one or more other agents useful for cancer therapy. In particular, the invention is directed to methods of treatment and prevention of cancer by the administration of a therapeutically or prophylactically effective amount of one or more antagonists of Integrin ?V?3 alone or in combination with standard and experimental therapies for treatment or prevention of cancer. Also included are methods for screening for epitope-specific Integrin ?V?3 antagonists which can be used according to the methods of the invention.
    Type: Application
    Filed: January 9, 2008
    Publication date: June 11, 2009
    Inventors: Richard Woessner, Peter Kiener, Melissa Dormitzer, William Walsh, Jon Heinrichs
  • Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
    Publication number: 20040001835
    Abstract: The present invention relates to methods and compositions designed for the treatment, management or prevention of cancer. The methods of the invention comprise the administration of an effective amount of one or more antagonists of Integrin &agr;V&bgr;3 alone or in combination with the administration of an effective amount of one or more other agents useful for cancer therapy. The invention also provides pharmaceutical compositions comprising one or more antagonists of Integrin &agr;V&bgr;3 and/or one or more other agents useful for cancer therapy. In particular, the invention is directed to methods of treatment and prevention of cancer by the administration of a therapeutically or prophylactically effective amount of one or more antagonists of Integrin &agr;V&bgr;3 alone or in combination with standard and experimental therapies for treatment or prevention of cancer.
    Type: Application
    Filed: March 4, 2003
    Publication date: January 1, 2004
    Applicant: MedImmune, Inc.
    Inventors: Richard Woessner, Peter Kiener, Melissa Dormitzer, William Walsh, Jon Heinrichs